The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program ...

The Washington Post yesterday published a letter to the editor from AHA President and CEO Rick Pollack responding to an April ...

Hospital and pharma groups have sharpened their spears for the rematch on 340B rebates.  | The administration's second stab ...

While it may be hard to believe, there is one issue in Washington that meets the above criteria: fixing the 340B program.

AHA urges HRSA to axe 340B model that would cost hospitals over $1 billion annually and increase administrative burdens.

The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking ...

Ravin Consultants announced today a leadership evolution that reflects the strength of its foundation and its long-term vision for the future of the 340B program. This press release features ...

A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have saved patients, taxpayers and employers billions of dollars. But fortunately ...

On July 31, 2025, the Health Resources and Services Administration (HRSA) released long-awaited guidance establishing a 340B Rebate Model Pilot Program (Pilot Program). The announcement marks a ...

On March 17, 2026, the Ninth Circuit issued a unanimous decision in United States ex rel. Adventist Health Sys. of W. v. AbbVie Inc. allowing a large health system to pursue a False Claims Act (FCA) ...

Add Yahoo as a preferred source to see more of our stories on Google. In a recent opinion piece, it was suggested the federal 340B Drug Pricing Program is contributing to rising employer health-care ...